ABSTRACT -Chemical characterization and acute and sub-acute toxicity study of Trikatu, a generic herbal formulation of Indian system of medicine, was carried out in Charles Foster (CF) rats for safety by the experimental animals (both male and female) and no changes were observed in mortality, morbidity, gross pathology, gain in weight, vital organ weight, hematological (total white blood cells (WBC) and red blood cells (RBC) count), biochemical parameters such as serum creatinine, serum glutamate oxaloa--sue biochemical parameters such as reduced glutathione and malonaldehyde content as oxidative stress markers. In sub-acute experiment, Trikatu was administered at 5, 50 and 300 mg/kg body weight once -300 mg/kg body weight, increase in SGPT activity at 50 mg/kg body weight and decrease in WBC count at 300 mg/kg body weight on 28 th day post treatment.
INTRODUCTION
Plants and plant-based deliverables are an important part of the health care system since ancient human civilization. The history of Indian health care system goes back to 5000 BC. Ancient Indian medical texts such as 'Charak Samhita' and 'Sushruta Samhita' were documented in about 1000 BC, where use of plants and poly herbal formulations were emphasized for health care and many of them are still in use in the Indian system of medicine (Mukherjee and Wahile, 2006) . One such polyherbal formulation is Trikatu, a Sanskrit word meaning three acrids. In Ayurveda, black pepper (Piper nigrum Linn.), long pepper (Piper longum Linn.) and ginger ( Rosc.) are collectively known as . It is prepared by mixing dried powder of fruits of black pepper, fruits of long pepper and rhizomes of ginger in the ratio of (1:1:1; W/W). The ancient documented Ayurvedic -mentions these three drugs as essential ingredients of various prescriptions and formulations used for a wide range of diseases (Atal ., 1981) . The active principle of Trikatu is an alkaloid piperine or 1 -peperoyl piperidine (Fagen ., 1995) . Literature has revealed a number of pharmacological properties of piperine, and one of ., 1984). Apart from its Ayurvedic use, several studies have reported enhancement of blood levels of drugs such as vasicine, sparteine, phenytoin, propranolol, theopylline, sulphadiazine and tetracycline (Bano ., 1987 (Bano ., , 1991 reduction in the blood level of diclofenac sodium, rifampicin (Lala ., 2004; Karan ., 1999) when coadministered with Trikatu or piperine. Trikatu capsule (500 mg) is available commercially in India and can be stored up to 2 years at room temperature. It has also the property of non-specific stimulation of immunity and also enhancement of vitality (Karan ., 1999) . All these aspects make Trikatu a drug of choice for several ailments in alternative medicine. However, the emergence of the safety issue of alternative medicine and increasing number of reports about the toxicity and/or adverse effects of Ayuurvedic and othSafety evaluation of Trikatu, a generic Ayurvedic medicine in Charles Foster rats er alternative medicinal ingredients and formulations in the last couple of years (Ernst, 1998) 
MATERIALS AND METHODS

Chemicals used
Malonaldehyde and reduced glutathione standard were purchased from Sigma Chemicals Ltd. (Bangalore, glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), total and high (Leverkusen, Germany). Other common chemicals used in the whole experiment were of Guaranteed Reagent (GR) grade and obtained from E-Merck India Ltd..
Animals
Male and Female Charles Foster (CF) rats of 6 to 8 weeks of age weighing (200 ± 25 g) were chosen for the study. The rats were maintained at 22 ± 5°C with humidity control and also on an automatic dark and light cycle of 12 hr. The animals were fed with the standard rat feed and provided drinking water.
Preparation and quality assurance of Trikatu
Trikatu was prepared following the procedure of Ayurvedic Formulary of India (2000) . All three ingredients of formulation were cultivated in the research farm of our Institute. The specimens were deposited in the gene bank. Formulation was prepared in three small batches (3 x 200 g). The quality of each batch was assured using the liquid chromatography photo diode array mass spectrometer (LC--printing LC-system (Shimadzu, Kyoto, Japan) that consist-5 photodiode array detector, and on-line mass spectromewas performed on LC Solution 3.41 (Shimadzu). 100 mg of Trikatu was sonicated (50 Hz) with methanol at 30°C re-dissolved in 5.0 ml of methanol. Stock solution of piperine (1 mg/ml) was prepared and diluted to obtain a linearity curve for quantitative analysis. 
Acute oral toxicity study
Ten adult male CF rats of 6 to 8 weeks age were taken of group 1 were considered as control and treated with distilled water while animals of group 2 were taken as experimental wherein the animals were treated with aqueous suspension of Trikatu at 2,000 mg/kg body weight as a single oral dose. The animals were observed for morbidity and mortality at 1, 2, 4 and 6 hr on the day of dosing and twice on the 7 th day. The body weights were recorded individually before and on 7 th day. The study was performed in accordance with Organisation for Economic No. 423 (1987) . Similar procedure was repeated for acute oral toxicity study with female CF rats where in 10 adult female rats were taken and experiment repeated as above.
Sub-acute oral toxicity study
In a repeated dose experiment, female rats were chosen because of their greater sensitivity (Ghosh, 1984) for which 20 rats were used and were divided into four -mals in each group. Animals of group 1 were kept as control and were treated with distilled water orally while animals of groups 2, 3 and 4 were treated with aqueous suspension of Trikatu at 5, 50 and 300 mg/kg body weight once orally for 28 days. Animals were observed for mortality, appearance and any signs of intoxications. Body weights were recorded at initiation, 14 th day and on 28 th day. The experimental protocols were duly approved by the Institutional Animal Ethics Committee and were in
In-life observation
The animals were checked daily for mortality and any signs of ill health. A daily general case side clinical examination before and after commencement of the experiment was carried out including changes in skin, mucous membrane, eyes, occurrence of secretion and excretion and also responses such as lachrymation, pilo-erection respiratory patterns etc. Changes in gait, posture and response to handling were also recorded (Allan ., 2007) .
Collection of samples
Blood samples were collected from all animals of the acute experiment on 0 th and 7 th day and were used for analysis of different biochemical parameters. The animals th days and were used for gross pathological study and measurement of differential organ weights.
Similarly, blood samples from all groups of animals of the sub-acute experiment were collected on 0 th , 14 th and 28 th days and were analyzed for different biochemical and used for gross pathological examinations including weight of different organs such as liver, kidney, lung, heart, brain, spleen, adrenal, ovary etc. Small pieces of liver tissues from experimental and control groups were homogenized in normal saline solution (10% homogenate). The homogenates thus obtained were centrifuged in a Biofuge Stratus at 3,000 rpm for 20 min at 4°C to -chemical assays.
Hematological and biochemical analysis
Neubawer's chamber was used to quantify the total red blood cells (RBC) and white blood cells (WBC) count. Serum biochemical parameters such as creati--mated using kits from Bayer Chemicals Ltd. in a semi auto-analyzer, RA 50 chemistry system from Bayer Ltd.. Hepatic reduced glutathione content was estimated as described by Rizvi and Luqman (2002) based on the method of Beutler (1971) . Oxidative stress marker level was estimated as described by Luqman and Rizvi (2006) based on Esterbauer and Cheeseman (1990) method hepatic tissues.
Statistical analysis
Effect of aqueous suspension of Trikatu in experimental conditions was analyzed using software (Instat) to derive the results (Mean ± S.E.). For non-parametric comparison, Turkey's test was employed using the same program.
RESULTS
The Trikatu formulation with piperine concentration 3.4% w/w (dry weight basis) was used for safety evaluation study. Exclusively piperine may not only be responsible for desired pharmacological actions, histopathological or biochemical effects of Trikatu. Therefore, the quality of the Trikatu formulation was demonstrated by reproseparation and methanol-water as mobile phase (detailed -gerprint of Trikatu along with its three constitutes are presented in Fig. 1 . Based on the total ion current chromatogram (TIC chromatogram), Trikatu has been shown to have 165 characteristic peaks and that of nigrum and were 119, 155 and 155 peaks respectively with common presence of piperine.
In life observations
Rats treated with Trikatu showed no observable changes either in acute experiment (at 2,000 mg/kg body weight) or sub-acute experiment (at 5, 50 and 300 mg/ kg body weight for 28 days). No morbidity or mortality was observed during the entire experimental period both in acute and sub-acute experiments. However, during the acute experiment, treated animals showed signs of inactivity and drowsiness for a period of thirty min and after two hr they were freed of these symptoms.
Body weight
In acute experiment, body weights were taken before and on the 7 th day after treatment with Trikatu at 2,000 mg/kg body weight. Body weight of control group was comparable to that of experimental group in both male and female rats in acute study (Tables 1 and 2 ). In subacute experiment, body weights were taken on 0, 14 th and 28 th day from all groups of animals. The absolute body weight was comparable in all experimental groups to that of control (Table 3) .
Differential organ weight
Mean values of absolute and relative weights (perVol. 34 No. 1 cent body weight) of different vital organs such as adrenal, kidney, liver, lung, brain, heart, spleen, testis, ovary etc. of treatment group were found to be comparable to that of control group in acute experiment (Figs. 2 and 3 ).
absolute and relative organ weights in sub-acute experiment with Trikatu when mean values of different treatment groups were compared to that of control (Fig. 4) .
Hematological and biochemical parameters
Trikatu at 2,000 mg/kg body weight did not induce (n = 5, * p < 0.05, ** p < 0.01, ***p < 0.001)
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Fig. 2.
Effect of trikatu at 2,000 mg/kg body weight as a single oral dose on differential organ weight (absolute and relative weight) Fig. 3 . Effect of trikatu at 2,000 mg/kg body weight as a single oral dose on differential organ weight (absolute and relative weight) Fig. 4 . Effect of trikatu at 5, 50 and 300 mg/kg body weight once orally for 28 days on differential organ weight (absolute and
Different vital organ Differential organs
either of the sex studied. Similarly, acute experiment with Trikatu showed no observable changes in biochemical parameters such as serum creatinine, SGOT, SGPT and -cal parameters (Tables 1 and 2 ). In sub-acute experiment with Trikatu at 5, 50 and 300 mg/kg body weight once orally for 28 days, no changes were observed in total RBC and WBC count in all experimental groups compared to control except animals of group 4 (300 mg/kg WBC count on 28 th day (Table 3) . Biochemical parameters studied in sub-acute experiments such as serum creatinine, triglycerides, total cholesterol and SGOT showed cholesterol level and SGPT activity showed significant changes in the experimental group. Group of animals treated with Trikatu at 300 mg/kg body weight showed th day -ol level were observed in animals treated with Trikatu at 50 and 300 mg/kg body weight on the 28 th day compared to respective controls (Table 3) . SGPT showed significant increase in activity in the group of animals treated with Trikatu at 50 mg/kg body weight on 28 th day (Table  3 ) although no change in activity was observed at higher dose (300 mg/kg body weight). Additionally, liver tissue homogenates from control and experimental groups of animals were analyzed for study of oxidative stress to level were observed in acute (Tables 1 and 2 ) and subacute experiment (Fig. 5) . Reduced gluthione content also and 2) and sub-acute experiments except the group of animals receiving Trikatu at 300 mg/kg body weight, which -tent (Fig. 6 ) compared to control.
DISCUSSION
tion due to paucity of methods to ensure the reproducible quality. Since the activity of herbal formulations are not because of single compounds, therefore the quality of the herbal formulation cannot be ensured by quantitative measurement of single, two or three marker compounds. The complex nature of phytochemicals is the main chal--gerprint based on photo diode detection is unable to differentiate Piper longum, Piper nigrum and Zingiber in Trikatu (Fig. 1) . The compounds having no chromophoric groups are not detected by this method. To under each peak and computed statistically by non-parametric test (p < 0.05). The test drug Trikatu was administered orally to CF rat at acute (2,000 mg/kg body weight as a single dose) and sub-acute doses at 5, 50 and 300 mg/kg body weight once daily for 28 days with the objective of determining the safety limit in our experimental condition so that data can be extrapolated to a human patient (Paget and Barnes, 1964) . No mortality or morbidity was observed throughout the experimental period. Non-significant changes were observed in absolute body weight in both acute and sub-acute experiments. Similarly, no changes were observed in vital organ weight measurement both in absolute and relative terms. Hematological parameters WBC count on 28 th day at 300 mg/kg body weight in subacute experiment. Likewise, most of the serum biochemical parameters like SGOT, serum creatinine, total choles--terol level at 300 mg/kg body weight, increase in SGPT activity at 50 mg/kg body weight on 28 th day post treatment. Trikatu at 2,000 mg/kg body weight did not show any changes in hepatic reduced glutathione content and oxidative stress indices (Tables 1 and 2 ). Trikatu at 300 reduced glutathione content of hepatic tissue compared to control (Fig. 6 ) although non-significant increase in reduced glutathione content was observed in lower dosestimated as a oxidative stress marker and non-significant changes were observed both in acute and sub acute a polyherbal formulation of much use in Ayurvedic Medicine. However, there are reports about the potential pharmacological and toxicological effects of piperine as such and some herbs containing piperine. Role of piperine in reversal of beryllium induced adverse effects was studied in rats and found that piperine at 10 mg/kg body weight was quite effective in the remediation of toxic response (Nirala ., 2008) . Similarly, piperine (1, 10 and 50 μg/ml) was found effective in cadmium induced alterations in murine thymocytes pertaining to its anti-oxidative, anti-apoptotic and restorative activity (Pathak and Khandelwal, 2006) . They found it to be a potent immunostimulant in immunocompromised murine thymocytes. Acute and sub-acute toxicity of piperine in mice, rats and hamsters was also carried out (Piyachaturawat ., 1983) . The workers found that piperine is acute--ue for mice was 15.1 mg/kg body weight as i.v. dose. The experimental animals died in sub-acute experiment with-. (2000) reported the potential reproductive toxicity of piperine in swice albino mice. Piperine at 10 and 20 mg/kg body weight produce decreased mating performance and fertility, loss of implantations including histopathological changes in the ovary and uterus. Similarly, piperine was also evaluated for immunotoxicological poten-., 2004) . Piperine at 1.12 mg/kg body weight did not show any immunotoxic (2.25 and 4.5 mg/kg body weight for 5 days) producing decrease in the weight of spleen, thymus and mesenteric lymph node, reduction in lymphocyte count so also serum antibody titer and cellular immune response. Shah . (1998) studied the acute and chronic toxicity of ethanolic extracts of Piper longum fruits and -bark containing piperine as one of the active constituents. These herbs are used as a spice and also as an ingredient in several alternative preparations. The workers recorded morphological, hematological changes including body weights and vital organ weights (Shah ., 1998). These extracts produced no mortality or morbidity during the study period. However, there was a decrease in liver weight, increase in lung and spleen weight and also a fall in hemoglobin level in chronic toxicity study. In a parallel type of study with leaf enriched extract at acute and sub-acute level in Sprague--erated at 500 mg/kg body weight for 14 days and also at 85, 210 and 500 mg/kg body weight for 90 days (Allan ., 2007) . However, there is no report on the toxicity proas such had no effect on the morbidity and mortality in our experiment including body weight, vital organ weight and major biochemical parameters studied. However, sig-300 mg/kg body weight, increase in SGPT activity at 50 mg/kg body weight and decrease in WBC count at 300 mg/kg body weight on 28 th day was observed in sub-acute study. From our observations, it can be concluded that Trikatu at 2,000 mg/kg body as a single dose orally in both male and female CF rats and at 5 mg/kg body weight once orally for 28 days is well tolerated by adult female CF rats.
